Cyramza Injection IP In Thane

Cyramza Ramucirumab Injections

Medical EvidenceGeneric name : Ramucirumab.Trade name : Cyramza.Manufacturer information :Cyramza is manufactured by Eli Lilly and Company.Cyramza FDA Approval :Cyramza First approved April 21st, 2014.Dosage form :Injection:100 mg/10 mL (10 mg per mL) solution, single-dose vial.500 mg/50 mL (10 mg per mL) solution, single-dose vial.Cyramza Indications and Usage :Gastric Cancer.Non-Small Cell Lung Cancer.Colorectal Cancer. Cyramza (Ramucirumab) availability in IndiaYou could import this medicine against import permit on Patient Name.Please contact ACT Lifesciences Private Limited for further information.